Neuroendocrine prostate cancer (NEPC) is a lethal, androgen receptor (AR)-independent subtype of prostate cancer that often arises after AR pathway inhibition and has limited treatment options. We hypothesized that NEPC might be susceptible to metabolic interventions targeting PIKfyve. Here, we iden...
ORGANISM(S): Homo sapiens